Not provided
Not provided
Not provided
Not provided
Difficulty enrollment; higher than planned patient attrition and data attrition
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The APPROPRIATE study will compare differences in functional capacity (peak VO2) between chronotropically incompetent patients randomized to receive rate responsive pacing driven by either the minute ventilation (respiration-based) sensor or an accelerometer (motion-based).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Accelerometer | Active Comparator | Patients implanted with a Boston Scientific ALTRUA 60 pacemaker with accelerometer (motion-based) sensor. |
|
| Minute Ventilation | Active Comparator | Patients implanted with a Boston Scientific ALTRUA 60 pacemaker with minute ventilation sensor. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rate adaptive pacemaker | Device | Accelerometer sensor |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Mean Change in Functional Capacity (Peak VO2). | The APPROPRIATE Study compared differences in functional capacity (peak VO2) between CI patients randomized to receive rate responsive pacing driven by either the minute ventilation (respiration-based) sensor or by an accelerometer (motion-based) sensor. The mean change in functional capactity will be compared against baseline; changes from baseline will be measured. | 1 month and 2 months post-implant |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Heart Rate During Activities of Daily Living (ADL) Using a Lift and Carry Test | This outcome measure will be compared against baseline. | 2 months post-implant |
| Metabolic Chronotropic Relationship (MCR) Slope |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Mobitz II second degree heart block
Third degree heart block
Chronic atrial fibrillation or uncontrolled atrial arrhythmias within the past 90 days prior to consent
Neuromuscular, orthopedic, or vascular disability that prevents normal walking or weight carrying (e.g., intermittent claudication, arthritis, residual stroke weakness, need for a wheelchair or walker)
A symptom-limited exercise protocol is thought to be dangerous or contra-indicated, including but not limited to changing pattern of chest discomfort or uncontrolled arrhythmias
Pulmonary disease as defined by any one of the following:
Life expectancy is less than 12 months due to other medical conditions, per physician discretion
Has or indicated for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D)
Currently enrolled in another investigational study that would directly impact the treatment or outcome of the current study.
Younger than 18 years of age
Pregnant or planning to become pregnant during the study (method of assessment upon physician's discretion)
Unable or unwilling to comply with the protocol requirements
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Giudici, MD | Genesis Heart Institute | Principal Investigator |
| F. Roosevelt Gilliam, MD | Cardiology Associates of NE Arkansas | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cardiology Association of NE Arkansas | Jonesboro | Arkansas | United States | |||
| Genesis Heart Institute |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Accelerometer | Accelerometer |
| FG001 | Minute Ventilation | Minute ventilation |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Accelerometer | Accelerometer |
| BG001 | Minute Ventilation | Minute ventilation |
| BG002 |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Mean Change in Functional Capacity (Peak VO2). | The APPROPRIATE Study compared differences in functional capacity (peak VO2) between CI patients randomized to receive rate responsive pacing driven by either the minute ventilation (respiration-based) sensor or by an accelerometer (motion-based) sensor. The mean change in functional capactity will be compared against baseline; changes from baseline will be measured. | Data was not analyzed since patient enrollment was ceased and study was prematurely terminated. | Posted | 1 month and 2 months post-implant |
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Accelerometer | Accelerometer | 0 |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Cardiovascular Adverse Events | Cardiac disorders |
Early termination leading to small numbers of subjects analyzed. As the study was stopped early, the primary objective is underpowered.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Director of Clinical Affairs | Boston Scientific | 651-582-2277 | cshd@bsci.com |
Not provided
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Rate adaptive pacemaker |
| Device |
Minute ventilation sensor |
|
| 1 month and 2 months post-implant |
| Exercise Time | 1 month and 2 months post-implant |
| VO2 at Ventilatory Threshold | 1 month and 2 months post-implant |
| Davenport |
| Iowa |
| United States |
| Total |
Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Units | Counts |
|---|---|
| Participants |
|
| Secondary | Changes in Heart Rate During Activities of Daily Living (ADL) Using a Lift and Carry Test | This outcome measure will be compared against baseline. | Data was not analyzed since patient enrollment was ceased and study was prematurely terminated. | Posted | 2 months post-implant |
|
|
| Secondary | Metabolic Chronotropic Relationship (MCR) Slope | Data was not analyzed since patient enrollment was ceased and study was prematurely terminated. | Posted | 1 month and 2 months post-implant |
|
|
|
| Secondary | Exercise Time | Data was not analyzed since patient enrollment was ceased and study was prematurely terminated. | Posted | 1 month and 2 months post-implant |
|
|
|
| Secondary | VO2 at Ventilatory Threshold | Data was not analyzed since patient enrollment was ceased and study was prematurely terminated. | Posted | 1 month and 2 months post-implant |
|
|
|
| 34 |
| 0 |
| 34 |
| 6 |
| 34 |
| EG001 | Minute Ventilation | Minute ventilation | 0 | 34 | 0 | 34 | 8 | 34 |
The first publication of the results shall be made a joint, multi-center publication.